香港健康产业论坛

返回主日程
09:00 - 12:00
  • 主持人 Moderator
  • 程琪清, 香港科技园公司创新发展商务发展（生命健康科技）高级经理
  • Rose CHING, Senior Manager,Business Development (Life and Health Technology), New Ventures,Hong Kong Science and Technology Parks Corporation
09:00 - 09:30
  • 第一阶段：致辞
  • Session I: Remarks
09:00 - 09:10
  • 致辞
  • Remarks
  • 于常海, 香港生物科技协会主席
  • Cheung-Hoi YU, Chairman of Hong Kong Biotechnology Organization
09:10 - 09:20
  • 致辞
  • Remarks
  • 黄秉修, 香港科技园公司行政总裁
  • Terry WONG, Chief Executive Officer of Hong Kong Science and Technology Parks Corporation
09:20 - 09:30
  • 致辞
  • Remarks
  • 廖丽芳, 香港生物医药创新协会总干事
  • Ruby LIAO, Chief Operating Officer of HK Bio-Med Innotech Association
09:30 - 11:10
  • 第二阶段：主题报告
  • Session II: Keynote Speech
09:30 - 09:50
  • 主题报告1
  • Keynote Speech 1
  • 香港建立与国际接轨的药械监管体系
  • Hong Kong to Build an Internationally-aligned Medical Products Regulatory System
  • 陈诗涛, 香港特别行政区政府卫生署助理署长
  • Lot CHAN, Assistant Director of Department of Health, Government of the Hong Kong Special Administrative Region
09:50 - 10:10
  • 主题报告2
  • Keynote Speech 2
  • 香港生物医药领域投资挑战与机遇
  • Biotech Investment Opportunities in Hong Kong
  • 梁传昕, 香港生物科技协会副会长，惠理集团私募投资合伙人
  • LEUNG Chuen Yan, Vice President of Hong Kong Biotechnology Organization, Partner (Private Investments) of Value Partners Group
10:10 - 10:30
  • 主题报告3
  • Keynote Speech 3
  • 香港创科生态赋能创新药企“出海”
  • Hong Kong's I&T Ecosystem Empowers Innovative Pharmaceutical Companies to Go Global
  • 谢丽娟, 香港科技园公司生命健康科技总监
  • Vicky TSE, Head of Life and Health Technology, Hong Kong Science and Technology Parks Corporation
10:30 - 10:50
  • 主题报告4
  • Keynote Speech 4
  • 双向赋能：香港FDA监管新政下内地创新药的国际化出海新路径
  • Mutual Empowerment: Leveraging Hong Kong’s New Regulatory Framework to Accelerate the Globalization of Mainland China’s Innovative Drugs
  • 门宇欣, 海昶生物首席医学官，白橡树集团首席执行官
  • MEN Yuxin, Chief Medical Officer of Haichang Biotech Co.,Ltd., Chief Executive Officer of WhiteOak Group Inc.
10:50 - 11:10
  • 主题报告5
  • Keynote Speech 5
  • 从发现到应用：从论文到产品的转化之路
  • From Discovery to Delivery: The Road from Publication to Product
  • 万钧, 香港科学工作者协会主席，香港大学外科系讲座教授，迈康因科技创始人兼董事
  • Kwan MAN, President of Hong Kong Scientist Association, Chair Professor of Transplant Oncology and Immunology, University of Hong Kong, Founder and Director of Oncoimmunostics Ltd.
11:10 - 12:00
  • 第三阶段：主题讨论
  • Session III: Panel
    • 主持人 Moderator
  • 赵孝斌, 海昶生物医药董事长、总经理
  • ZHAO Xiaobin, Chairman of the Board, General Manager of Haichang Biotech Co., Ltd.
11:10 - 12:00
  • 主题讨论
  • Panel
  • 扬帆 “十五五”，香港如何成为国际医药创新与转化枢纽
  • Setting Sail for the 15th Five-Year Plan: Building Hong Kong as an International Hub for Pharmaceutical Innovation and Translation
    • 讨论嘉宾：
    Panelist:
  • 康韦, 粤港澳大湾区医药创新联合会创始人
  • KANG Wei, Founder & Chief Advisor of GBAAPI
  • 宇文镐, 博士，斯丹姆医药全球注册高级副总裁兼首席商务官
  • Howard YUWEN, SVP & CBO at SDM Bioservices
  • 余刚, 华领医药法规事务副总裁
  • YU Gang, VP, Regulatory Affairs of Hua Medicine
  • 劳远至, 先声药业香港协同创新中心总经理
  • LAO Yuanzhi, Senior Director, Hong Kong Collaborative Innovation Center Simcere Pharmaceutical Group
  • 刘江, 香港大学外科学系研究助理教授，迈康因科技研发负责人
  • LIU Jiang, Research Assistant Professor of Department of Surgery of The University of Hong Kong, Research Lead of Oncoimmunostics Ltd.